It is also being studied as a potential treatment for obstructive sleep apnea and hypertension in adults with obesity
For broader context on this developing medication, see Retatrutide Access and Safety
While this is a key research area, we propose that further investigations should verify whether GLP-1RAs may also affect cognitive and behavioral symptoms seen in psychosis, as suggested by their potential to influence neurobiological (for example, immune function) and neuropsychological (for example, reward) mechanisms that are known to be disrupted in psychotic illness
Tirzepatide is sold as Mounjaro for T2D and Zepbound for obesity in the US, and the two brands grew 110% and 123% to $7.41 billion and $4.26 billion, respectively, in the last quarter of 2025, year-on-year
People prescribed GLP1 medications for weight loss now have options that do not require injections
Reta Peptide Research Applications Current scientific studies are exploring Retatrutide in the context of: Metabolic regulation and energy balance Appetite signalling pathways Glucose utilisation and insulin response models Body composition research Lipid metabolism and fat-oxidation mechanisms Multi-hormonal receptor activation studies These applications are based on ongoing research and are provided strictly for scientific and laboratory context